Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert Van Assche

Showing results (71-80 of 287) with videos related to

Pageof 29
Sort By:
World Journal of Gastroenterology|May 10, 2018
Endoscopic management of Crohn's stricturesTalat Bessissow, Jason Reinglas, Achuthan Aruljothy, et al.
Gut|August 25, 2010
Serum S100A12 as a new marker for inflammatory bowel disease and its relationship with disease activityMarko Brinar, Isabelle Cleynen, Tamara Coopmans, et al.
Journal of Gastroenterology and Hepatology|July 22, 2014
Serological markers associated with disease behavior and response to anti-tumor necrosis factor therapy in ulcerative colitisDavid Kevans, Matti Waterman, Raquel Milgrom, et al.
Inflammatory Bowel Diseases|June 24, 2005
Hyperresponsiveness of the mucosal barrier in Crohn's disease is not tumor necrosis factor-dependentPeter Suenaert, Veerle Bulteel, Severine Vermeire, et al.
Inflammatory Bowel Diseases|December 18, 2014
Aeromonas species: an opportunistic enteropathogen in patients with inflammatory bowel diseases? A single center cohort studyTriana Lobatón, Ilse Hoffman, Severine Vermeire, et al.
Gut|January 19, 2007
Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's diseaseSeverine Vermeire, Maja Noman, Gert Van Assche, et al.
Clinical Immunology (Orlando, Fla.)|May 17, 2005
Infliximab induces apoptosis of monocytes and T lymphocytes in a human-mouse chimeric modelChong Shen, Philippe Maerten, Karel Geboes, et al.
Inflammatory Bowel Diseases|March 15, 2006
Evaluation of short-term responsiveness and cutoff values of inflammatory bowel disease questionnaire in Crohn's diseaseTibor Hlavaty, Philippe Persoons, Severine Vermeire, et al.
Inflammatory Bowel Diseases|October 25, 2011
Therapeutic drug monitoring of biologics for inflammatory bowel diseaseJean-Frédéric Colombel, Brian G Feagan, William J Sandborn, et al.
The American Journal of Gastroenterology|June 6, 2013
5-aminosalicylate is not protective from neoplasia in ulcerative colitisTalat Bessissow, Raf Bisschops, M Ferrante, et al.
Pageof 29

Showing results (71-80 of 287) with videos related to

Sort By:
Pageof 29
World Journal of Gastroenterology|May 10, 2018
Endoscopic management of Crohn's stricturesTalat Bessissow, Jason Reinglas, Achuthan Aruljothy, et al.
Gut|August 25, 2010
Serum S100A12 as a new marker for inflammatory bowel disease and its relationship with disease activityMarko Brinar, Isabelle Cleynen, Tamara Coopmans, et al.
Journal of Gastroenterology and Hepatology|July 22, 2014
Serological markers associated with disease behavior and response to anti-tumor necrosis factor therapy in ulcerative colitisDavid Kevans, Matti Waterman, Raquel Milgrom, et al.
Inflammatory Bowel Diseases|June 24, 2005
Hyperresponsiveness of the mucosal barrier in Crohn's disease is not tumor necrosis factor-dependentPeter Suenaert, Veerle Bulteel, Severine Vermeire, et al.
Inflammatory Bowel Diseases|December 18, 2014
Aeromonas species: an opportunistic enteropathogen in patients with inflammatory bowel diseases? A single center cohort studyTriana Lobatón, Ilse Hoffman, Severine Vermeire, et al.
Gut|January 19, 2007
Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's diseaseSeverine Vermeire, Maja Noman, Gert Van Assche, et al.
Clinical Immunology (Orlando, Fla.)|May 17, 2005
Infliximab induces apoptosis of monocytes and T lymphocytes in a human-mouse chimeric modelChong Shen, Philippe Maerten, Karel Geboes, et al.
Inflammatory Bowel Diseases|March 15, 2006
Evaluation of short-term responsiveness and cutoff values of inflammatory bowel disease questionnaire in Crohn's diseaseTibor Hlavaty, Philippe Persoons, Severine Vermeire, et al.
Inflammatory Bowel Diseases|October 25, 2011
Therapeutic drug monitoring of biologics for inflammatory bowel diseaseJean-Frédéric Colombel, Brian G Feagan, William J Sandborn, et al.
The American Journal of Gastroenterology|June 6, 2013
5-aminosalicylate is not protective from neoplasia in ulcerative colitisTalat Bessissow, Raf Bisschops, M Ferrante, et al.
Pageof 29